Advances in mass spectrometry-based clinical biomarker discovery

The greatest unmet needs in biomarker discovery are those discoveries that lead to the development of clinical diagnostic tests. These clinical diagnostic tests can provide early intervention when a patient would present otherwise healthy (e.g., cancer or cardiovascular disease) and aid clinical dec...

Descripción completa

Detalles Bibliográficos
Autores principales: Crutchfield, Christopher A., Thomas, Stefani N., Sokoll, Lori J., Chan, Daniel W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4705754/
https://www.ncbi.nlm.nih.gov/pubmed/26751220
http://dx.doi.org/10.1186/s12014-015-9102-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4705754/
https://www.ncbi.nlm.nih.gov/pubmed/26751220
http://dx.doi.org/10.1186/s12014-015-9102-9

Ejemplares similares